Changes in leadership of breast cancer research and treatment
Endoscopic breast surgery: where are we now and what might the future hold for video-assisted breast surgery?
Triple negative breast cancer: unmet medical needs
Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancer
Breast cancer prognostic markers in the post-genomic era
Mutations and polymorphic BRCA variants transmission in breast cancer familial members
Inhibition of focal adhesion kinase suppresses the adverse phenotype of endocrine-resistant breast cancer cells and improves endocrine response in endocrine-sensitive cells
COX2 expression in prognosis and in prediction to endocrine therapy in early breast cancer patients
Tumor-stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients
Genomics, histopathology, and the tumor microenvironment: new relationship or old friends re-discovered?
Involvement of MyoD and c-myb in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene
Coexpression of atypical chemokine binders (ACBs) in breast cancer predicts better outcomes
Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern
Disseminated tumor cells: the method is the message
Anastrozole and letrozole: an investigation and comparison of quality of life and tolerability
One size does not fit all: quality of life during adjuvant aromatase inhibitor therapy
Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies
Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy
Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1-3 node-positive rapidly proliferating breast cancer
Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer
Evaluation of estrogen and progesterone receptors in non-neoplastic breast tissue of women of reproductive age exposed to tamoxifen and raloxifene: a randomized, double-blind study
Outcomes following local therapy for early-stage breast cancer in non-trial populations
Supraclavicular recurrence after early breast cancer: a curable condition?
Breast cancer in the supraclavicular region: is the horse out of the barn?
RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies
Comparative effectiveness of screening and prevention strategies among BRCA1/2 -affected mutation carriers
Association of a vascular endothelial growth factor gene 936 C/T polymorphism with breast cancer risk: a meta-analysis
The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers
Polymorphic variants in TSC1 and TSC2 and their association with breast cancer phenotypes
Vitamin D threshold to prevent aromatase inhibitor-induced arthralgia: a prospective cohort study
Gene expression array testing of FFPE archival breast tumor samples: an optimized protocol for WG-DASL® sample preparation
Two novel variants in the 3′UTR of the BRCA1 gene in familial breast and/or ovarian cancer
A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance